Skip to main content

Advertisement

SpringerLink
Log in

Obesity and cardiovascular disease

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Obesity is a major contributor to the prevalence of cardiovascular disease in the developed world, and yet has only recently been afforded the same level of attention as other risk factors of coronary artery disease. Obesity is a chronic metabolic disorder associated with cardiovascular disease and increased morbidity and mortality. It is apparent that a variety of adaptations/alterations in cardiac structure and function occur as excessive adipose tissue accumulates, even in the absence of comorbidities. Shifts toward a less physically demanding lifestyle are observed today throughout different populations, and this scourge associated with obesity implicates a corresponding increase in the number of individuals afflicted with the metabolic syndrome, which defines the obese patient as being “at risk.” Adipose tissue is not simply a passive storehouse for fat, but an endocrine organ that is capable of synthesizing and releasing into the bloodstream a variety of molecules that may impact unfavorably the risk factor profile of a patient. Indeed, obesity may affect atherosclerosis through unrecognized variables and risk factors for coronary artery disease such as dyslipidemia, hypertension, glucose intolerance, inflammatory markers, and the prothrombotic state. By favorably modifying lipids, decreasing blood pressure, and decreasing levels of glycemia, proinflammatory cytokines, and adhesion molecules, weight loss may prevent the progression of atherosclerosis or the occurrence of acute coronary syndrome events in the obese high-risk population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Poirier P, Eckel RH: The heart and obesity. In Hurst’s The Heart. Edited by Fuster V, Alexander RW, King S, et al.: New York: McGraw-Hill; 2000:2289–2303.

    Google Scholar 

  2. Eckel RH, Krauss RM: American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998, 97:2099–2100.

    PubMed  CAS  Google Scholar 

  3. Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ: Obesity prevention: the case for action. Int J Obes Relat Metab Disord 2002, 26:425–436.

    Article  PubMed  CAS  Google Scholar 

  4. Rabkin SW, Mathewson FA, Hsu PH: Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 1977, 39:452–458.

    Article  PubMed  CAS  Google Scholar 

  5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.

  6. Larsson B, Svardsudd K, Welin L, et al.: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. BMJ 1984, 288:1401–1404.

    PubMed  CAS  Google Scholar 

  7. Folsom AR, Kaye SA, Sellers TA, et al.: Body fat distribution and 5-year risk of death in older women. JAMA 1993, 269:483–487.

    Article  PubMed  CAS  Google Scholar 

  8. Rexrode KM, Carey VJ, Hennekens CH, et al.: Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280:1843–1848.

    Article  PubMed  CAS  Google Scholar 

  9. Lemieux I, Pascot A, Couillard C, et al.: Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000, 102:179–184.

    PubMed  CAS  Google Scholar 

  10. Tchernof A, Lamarche B, Prud’homme D, et al.: The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996, 19:629–637.

    Article  PubMed  CAS  Google Scholar 

  11. Couillard C, Bergeron N, Prud’homme D, et al.: Postprandial triglyceride response in visceral obesity in men. Diabetes 1998, 47:953–960.

    Article  PubMed  CAS  Google Scholar 

  12. Pascot A, Lemieux I, Prud’homme D, et al.: Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 2001, 42:2007–2014.

    PubMed  CAS  Google Scholar 

  13. Lemieux S, Després JP: Metabolic complications of visceral obesity: contribution to the etiology of type 2 diabetes and implications for prevention and treatment. Diabetes Metab 1994, 20:375–393.

    CAS  Google Scholar 

  14. Juhan-Vague I, Alessi MC: PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997, 78:656–660.

    PubMed  CAS  Google Scholar 

  15. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999, 19:972–978.

    PubMed  CAS  Google Scholar 

  16. Hak AE, Stehouwer CD, Bots ML, et al.: Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999, 19:1986–1991.

    PubMed  CAS  Google Scholar 

  17. Pascot A, Poirier P, Lemieux I, Després JP: Caractère distinct de la plaque athéromateuse du patient insulinorésistant diabétique. Ann Endocrinol (Paris) 2001, 62:267–273.

    CAS  Google Scholar 

  18. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000, 148:209–214.

    Article  PubMed  CAS  Google Scholar 

  19. Folsom AR, Qamhieh HT, Wing RR, et al.: Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb 1993, 13:162–169.

    PubMed  CAS  Google Scholar 

  20. Cigolini M, Targher G, Bergamo AI, et al.: Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996, 16:368–374.

    PubMed  CAS  Google Scholar 

  21. Svendsen OL, Hassager C, Christiansen C, Nielsen JD, Winther K: Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: effect of dieting with or without exercise in overweight postmenopausal women. Arterioscler Thromb Vasc Biol 1996, 16:381–385.

    PubMed  CAS  Google Scholar 

  22. Licata G, Scaglione R, Avellone G, et al.: Hemostatic function in young subjects with central obesity: relationship with left ventricular function. Metabolism 1995, 44:1417–1421.

    Article  PubMed  CAS  Google Scholar 

  23. Steinberg HO, Chaker H, Leaming R, et al.: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996, 97:2601–2610.

    PubMed  CAS  Google Scholar 

  24. Hashimoto M, Akishita M, Eto M, et al.: The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 1998, 22:477–484.

    Article  PubMed  CAS  Google Scholar 

  25. Grundy SM: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002, 105:2696–2698.

    Article  PubMed  Google Scholar 

  26. Mohamed-Ali V, Goodrick S, Rawesh A, et al.: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997, 82:4196–4200.

    Article  PubMed  CAS  Google Scholar 

  27. Ridker PM: Novel risk factors and markers for coronary disease. Adv Intern Med 2000, 45:391–418.

    PubMed  CAS  Google Scholar 

  28. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT: Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002, 23:706–713.

    Article  PubMed  Google Scholar 

  29. Bogaty P, Poirier P, Simard S, et al.: Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 2001, 103:3062–3068.

    PubMed  CAS  Google Scholar 

  30. Bogaty P, Robitaille NM, Solymoss S, et al.: Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina. Am Heart J 1998, 136:884–893.

    Article  PubMed  CAS  Google Scholar 

  31. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998, 15:539–553.

    Article  CAS  Google Scholar 

  32. Isomaa B, Almgren P, Tuomi T, et al.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683–689.

    Article  PubMed  CAS  Google Scholar 

  33. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356–359.

    Article  PubMed  Google Scholar 

  34. Pyorala M, Miettinen H, Laakso M, Pyorala K: Hyperinsulinemia predicts coronary heart disease risk in healthy middle- aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998, 98:398–404.

    PubMed  CAS  Google Scholar 

  35. Després JP, Lamarche B, Mauriege P, et al.: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996, 334:952–957.

    Article  PubMed  Google Scholar 

  36. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. Obes Res 1998, 2(suppl):51S-209S.

    Google Scholar 

  37. Williams IL, Wheatcroft SB, Shah AM, Kearney MT: Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes Relat Metab Disord 2002, 26:754–764.

    Article  PubMed  CAS  Google Scholar 

  38. McGill HC: Fatty streaks in the coronary arteries and aorta. Lab Invest 1968, 18:560–564.

    PubMed  Google Scholar 

  39. Skalen K, Gustafsson M, Rydberg EK, et al.: Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002, 417:750–754.

    Article  PubMed  CAS  Google Scholar 

  40. McGill HC Jr, McMahan CA, Herderick EE, et al.: Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 2000, 72:1307S-1315S.

    PubMed  CAS  Google Scholar 

  41. Berenson GS: Bogalusa Heart Study: a long-term community study of a rural biracial (Black/White) population. Am J Med Sci 2001, 322:293–300.

    Article  PubMed  CAS  Google Scholar 

  42. Enos WF, Holmes RH, Beyer J: Coronary disease among United States soldiers killed in action in Korea. JAMA 1953, 152:1090–1093.

    CAS  Google Scholar 

  43. McGill HC, McMahan CA, Malcom GT, Oalmann MC, Strong JP: Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995, 15:431–440.

    PubMed  Google Scholar 

  44. Zieske AW, Malcom GT, Strong JP: Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 2002, 21:213–237.

    Article  PubMed  Google Scholar 

  45. McGill HC Jr, McMahan CA, Herderick EE, et al.: Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002, 105:2712–2718.

    Article  PubMed  Google Scholar 

  46. McGill HC, McMahan CA, Zieske AW, et al.: Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000, 102:374–379.

    PubMed  Google Scholar 

  47. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968–977.

    PubMed  CAS  Google Scholar 

  48. Eckel RH: Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997, 96:3248–3250.

    PubMed  CAS  Google Scholar 

  49. Deckelbaum RJ, Williams CL: Childhood obesity: the health issue. Obes Res 2001, 9(suppl 4):239S-243S.

    PubMed  Google Scholar 

  50. James PT, Leach R, Kalamara E, Shayeghi M: The worldwide obesity epidemic. Obes Res 2001, 9(suppl 4):228S-233S.

    PubMed  Google Scholar 

  51. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS: Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 2001, 108:712–718.

    Article  PubMed  CAS  Google Scholar 

  52. Holman RL: Atherosclerosis-a pediatric nutrition problem? Am J Clin Nutr 1961, 9:565–569.

    PubMed  CAS  Google Scholar 

  53. Poirier P, Després JP: Exercise in weight management of obesity. Cardiol Clin 2001, 19:459–470.

    Article  PubMed  CAS  Google Scholar 

  54. Morrison JA, James FW, Sprecher DL, Khoury PR, Daniels SR: Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975-1990: the Princeton School Study. Am J Public Health 1999, 89:1708–1714.

    Article  PubMed  CAS  Google Scholar 

  55. Morrison JA, Barton BA, Biro FM, Daniels SR, Sprecher DL: Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr 1999, 135:451–457.

    Article  PubMed  CAS  Google Scholar 

  56. Otsuka Y, Miyazaki S, Okumura H, et al.: Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty. Eur Heart J 2000, 21:1790–1796.

    Article  PubMed  CAS  Google Scholar 

  57. Korpilahti K, Syvanne M, Engblom E, et al.: Components of the insulin resistance syndrome are associated with progression of atherosclerosis in non-grafted arteries 5 years after coronary artery bypass surgery. Eur Heart J 1998, 19:711–719.

    Article  PubMed  CAS  Google Scholar 

  58. Eisenstein EL, Shaw LK, Nelson CL, et al.: Obesity and long-term clinical and economic outcomes in coronary artery disease patients. Obes Res 2002, 10:83–91.

    Article  PubMed  Google Scholar 

  59. Gruberg L, Weissman NJ, Waksman R, et al.: The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002, 39:578–584.

    Article  PubMed  Google Scholar 

  60. Marik P, Varon J: The obese patient in the ICU. Chest 1998, 113:492–498.

    PubMed  CAS  Google Scholar 

  61. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M: Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation 1996, 94:II87-II92.

    PubMed  CAS  Google Scholar 

  62. Birkmeyer NJ, Charlesworth DC, Hernandez F, et al.: Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1998, 97:1689–1694.

    PubMed  CAS  Google Scholar 

  63. Tenkanen L, Manttari M, Manninen V: Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study. Circulation 1995, 92:1779–1785.

    PubMed  CAS  Google Scholar 

  64. Bloomfield Rubins H, Davenport J, Babikian V, et al.: Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 2001, 103:2828–2833.

    PubMed  CAS  Google Scholar 

  65. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 1999, 281:1291–1297.

    Article  PubMed  CAS  Google Scholar 

  66. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.

    Article  PubMed  CAS  Google Scholar 

  67. Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.

    Article  PubMed  CAS  Google Scholar 

  68. Ziccardi P, Nappo F, Giugliano G, et al.: Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002, 105:804–809.

    Article  PubMed  CAS  Google Scholar 

  69. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET: Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002, 105:564–569.

    Article  PubMed  Google Scholar 

  70. Heilbronn LK, Noakes M, Clifton PM: Energy restriction and weight loss on very-low-fat diets reduce C- reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001, 21:968–970.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Universitaire de Cardiologie et de Pneumologie, Hôspital Laval, 2725 Chemin Sainte-Foy, G1V 4G5, Sainte-Foy, Québec, Canada

    Paul Poirier MD, PhD, FRCPC & Robert H. Eckel MD

Authors
  1. Paul Poirier MD, PhD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert H. Eckel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poirier, P., Eckel, R.H. Obesity and cardiovascular disease. Curr Atheroscler Rep 4, 448–453 (2002). https://doi.org/10.1007/s11883-002-0049-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-002-0049-8

Keywords

Search

Navigation